CAMBRIDGE, Mass., July 20, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare disorders, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. ET on Wednesday, August 8, 2012, to provide a business update and discuss its second quarter 2012 financial and operational results.
